First-in-Human Phase I Trial Combining Biologically Guided Radioimmunotherapy (RIT) Using a 90Y-Anti-CD25 Monoclonal Antibody (Mab) with CT-guided Total Marrow and Lymphoid Irradiation (TMLI) in Relapsed and Refractory (R/R) Acute Leukemia
| Autor: | Wong, J.Y.C., Monzr, A.M., Sahebi, F., Dandapani, S.V., Yamauchi, D.M., Salhotra, A., Adhikarla, V., Ali, H., Poku, E., Yang, D., Han, C., Liu, A., Mokhtari, S., Wu, A., Yazaki, P., Shively, J.E., Hui, S.K., Smith, E., Stein, A. |
|---|---|
| Zdroj: | In International Journal of Radiation Oncology, Biology, Physics 1 October 2023 117(2) Supplement:S162-S162 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|